InMed Pharmaceuticals Correlations

INM Stock

USD 4.50 0.16 3.43%

The current 90-days correlation between InMed Pharmaceuticals and Quoin Pharmaceuticals Ltd is -0.11 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InMed Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InMed Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

InMed Pharmaceuticals Correlation With Market

Significant diversification

The correlation between InMed Pharmaceuticals and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding InMed Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InMed Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in InMed Stock, please use our How to Invest in InMed Pharmaceuticals guide.

Moving together with InMed Stock

0.62	EQ	Equillium	Pair Corr
0.71	VALN	Valneva SE ADR	Pair Corr
0.62	MDWD	Mediwound	Pair Corr
0.78	BACK	IMAC Holdings	Pair Corr

Moving against InMed Stock

0.38	NXGLW	NexGel Warrant	Pair Corr
0.35	RNXT	RenovoRx	Pair Corr
0.33	KZR	Kezar Life Sciences	Pair Corr
0.65	T	ATT Inc Sell-off Trend	Pair Corr
0.64	HD	Home Depot	Pair Corr
0.58	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr
0.55	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr
0.53	GE	GE Aerospace Fiscal Year End 28th of January 2025	Pair Corr
0.53	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr
0.46	MCD	McDonalds Fiscal Year End 3rd of February 2025	Pair Corr
0.44	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.43	DD	Dupont De Nemours Fiscal Year End 4th of February 2025	Pair Corr
0.34	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.31	HPQ	HP Inc	Pair Corr

Related Correlations Analysis

	QNRX	ALLR	KRBP	VRAX	BDRX	ICU	VIRI	ZVSA	SONN	REVB
QNRX		0.09	-0.06	0.12	0.06	-0.08	0.01	0.03	0.01	0.13	QNRX
ALLR	0.09		0.66	0.92	0.92	0.77	0.65	0.7	0.56	0.74	ALLR
KRBP	-0.06	0.66		0.48	0.67	0.77	0.53	0.63	0.72	0.33	KRBP
VRAX	0.12	0.92	0.48		0.9	0.62	0.6	0.57	0.39	0.82	VRAX
BDRX	0.06	0.92	0.67	0.9		0.82	0.71	0.75	0.61	0.8	BDRX
ICU	-0.08	0.77	0.77	0.62	0.82		0.73	0.91	0.86	0.5	ICU
VIRI	0.01	0.65	0.53	0.6	0.71	0.73		0.77	0.57	0.5	VIRI
ZVSA	0.03	0.7	0.63	0.57	0.75	0.91	0.77		0.79	0.49	ZVSA
SONN	0.01	0.56	0.72	0.39	0.61	0.86	0.57	0.79		0.24	SONN
REVB	0.13	0.74	0.33	0.82	0.8	0.5	0.5	0.49	0.24		REVB
	QNRX	ALLR	KRBP	VRAX	BDRX	ICU	VIRI	ZVSA	SONN	REVB

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

VRAX	+ 0.92	ALLR
BDRX	+ 0.92	ALLR
ZVSA	+ 0.91	ICU
BDRX	+ 0.9	VRAX
SONN	+ 0.86	ICU
REVB	+ 0.82	VRAX

High negative correlations

ICU	- 0.08	QNRX
KRBP	- 0.06	QNRX

Risk-Adjusted Indicators

There is a big difference between InMed Stock performing well and InMed Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze InMed Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
QNRX	6.20	0.30	0.05	0.30	6.79	(8.68)	17.65	(9.68)	74.46
ALLR	4.99	(2.02)	0.00	(1.99)	0.00	0.00	10.85	(16.11)	41.48
KRBP	6.00	(0.33)	0.00	(0.12)	0.00	0.00	12.04	(10.96)	65.24
VRAX	5.88	(1.00)	0.00	2.57	0.00	0.00	9.65	(12.97)	61.28
BDRX	6.68	(1.51)	0.00	(0.35)	0.00	0.00	11.91	(17.24)	97.78
ICU	3.99	(1.67)	0.00	(1.25)	0.00	0.00	5.49	(8.67)	31.31
VIRI	5.85	(0.17)	0.00	0.22	0.00	0.00	12.46	(10.62)	50.54
ZVSA	4.12	(0.89)	0.00	0.54	0.00	0.00	7.57	(9.60)	78.93
SONN	4.76	(0.86)	0.00	1.49	0.00	0.00	12.31	(9.79)	37.58
REVB	3.65	(0.83)	0.00	(0.30)	0.00	0.00	8.97	(7.83)	34.52

InMed Pharmaceuticals Corporate Management

Sazzad MSc	CoFounder	Profile
Ado Muhammad	Consultant Affairs	Profile
Colin Clancy	Director Relations	Profile
Eric Hsu	Senior Development	Profile
Jerry Griffin	Vice Marketing	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC